On June 30th, 2020, America Great Health (the “Company”) and Purecell Group (“Purecell”), a leading anti-aging medical institution in Australia, entered into a Cooperation Agreement, in which the Company agreed to acquire 51% of the equity of Purecell, as consideration, the Company shall issue 510,000,000 common shares to Purecell’s nominated trustee. Upon completion of the acquisition transaction, Purecell shall remain autonomous in its day to day operation, including recruiting and retaining management team members.
On February 10th, 2021, the Company completed its financial and legal due diligence and consummated the acquisition of Purecell, with a total of 510,000,000 common shares transferred to Purecell’s nominated trustee.